<DOC>
	<DOCNO>NCT00898495</DOCNO>
	<brief_summary>RATIONALE : Studying sample tissue laboratory patient cancer may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict patient 's response treatment . PURPOSE : This laboratory study look gene see predict outcome patient esophageal cancer treat cisplatin , radiation therapy , surgery .</brief_summary>
	<brief_title>Genes Predicting Outcome Patients With Esophageal Cancer Treated With Cisplatin , Radiation Therapy , Surgery</brief_title>
	<detailed_description>OBJECTIVES : - Correlate patient outcome neoplastic cell genotype , specifically 18 single nucleotide polymorphism ( SNPs ) 16 major gene involve platinum metabolism disposition DNA repair , patient esophageal cancer treat neoadjuvant cisplatin-based chemoradiotherapy follow surgical resection clinical trial ECOG-1201 . - Correlate patient outcome neoplastic cell genotype , specifically loss heterozygosity , patient . - Correlate patient outcome normal ( germline ) cell genotype , specifically SNPs relate platinum metabolism disposition DNA repair . - Compare predictive ability neoplastic v germline cell genotype . OUTLINE : This retrospective , cohort , multicenter study . Neoplastic normal ( germline ) cell collect pretreatment post-treatment specimen use laser-capture microdissection . Single nucleotide polymorphism examine real-time PCR . Loss heterozygosity assess analyze short tandem repeat marker neoplastic germline tissue .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis adenocarcinoma esophagus Stage IIV disease Received cisplatinbased treatment clinical trial ECOG1201 PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>adenocarcinoma esophagus</keyword>
	<keyword>stage II esophageal cancer</keyword>
	<keyword>stage III esophageal cancer</keyword>
	<keyword>stage IV esophageal cancer</keyword>
	<keyword>stage I esophageal cancer</keyword>
</DOC>